Atorvastatin has no evidence of significant damage to the kidneys and can cause some damage mainly to the liver and muscles.
Atorvastatin belongs to lipid-lowering drugs, specific inhibition of cholesterol, the main indication is hypercholesterolemia. The process of taking atorvastatin will not cause significant damage to the kidneys, and patients with kidney disease can take it appropriately if indicated.
Atorvastatin can cause damage to the liver, which can lead to an increase in transaminases, and some patients may even have severe liver function impairment, which may be related to the metabolism of the drug in the liver.
Atorvastatin can also cause rhabdomyolysis, leading to elevated creatine kinase levels.
During the course of taking atorvastatin, the monitoring of liver function and creatine kinase should be strengthened, and the occurrence of serious adverse reactions should be timely to the hospital, under the guidance of the physician’s treatment.